HOSPIRA AUSTRALIA PTY LTD
Hospira Inc., headquartered in Lake Forest, USA, is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™.
As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, such as its Paclitaxel Injection (Anzatax®) for the treatment of advanced lung, breast or ovary cancer (amongst others) as well as integrated infusion therapy and medication management solutions. Hospira is also a leading provider of contract manufacturing services to proprietary pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. Its broad portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
The name ‘Hospira’ is derived from the words hospital, spirit, inspire and the Latin word spero, which means hope. It reflects the company’s primary market focus and expresses the hope and optimism that are critical in the healthcare industry.
Hospira’s vision - Advancing Wellness™ through the right people and the right products - guides all the company’s efforts and is its very purpose. Created from the core hospital products business of Abbott Laboratories, the company takes a proactive approach to improving patient and healthcare worker safety.
Through its offering of high-quality, lower-cost alternatives to proprietary medications, Hospira continues to help reduce the overall costs of healthcare - to improve both the affordability of care for patients and the financial strength of the global healthcare system. The company also is a pioneer in providing innovative solutions to improve patient and healthcare worker safety.
By confirming the accuracy of the drug, dose, patient, time, and route, medication errors at the bedside can be prevented before an ADE (Adverse drug event) occurs. Medication Management Solutions, with bar code capabilities, are devised to help caregivers confirm these five rights and reduce medication errors. Hospira is committed to helping hospitals reduce medication errors and improve patient safety by applying bar codes to all injectable drugs and I.V. solutions.
Hospira Australia is an integral part of the Hospira Inc., global operations in the Asia Pacific region. It is the home of one of Hospira’s key manufacturing plants, located at Mulgrave, and the company offers a diverse range of products and services to its hospital customers including an extensive range of generic injectable products, specialist hospital products, general infusion and pain management pumps, waste disposal systems, and needleless administration equipment. Recent product introductions include the sedation agent Precedex® (dexmedetomidine hydrochloride) Injection, advanced sensory catheters and hemodynamic monitoring devices.
Hospira Australia is located in Melbourne, which doubles as the Asia Pacific regional headquarters and has a devices service centre and office in Sydney. Hospira Specialist Product Representatives, Key Account Managers and Clinical Educators support every state and territory.
By working with its customers to integrate technologies at the point of care, Hospira is the partner of choice for improving patient and workplace safety, clinical outcomes and cost management, and caregiver efficiency and effectiveness.
New releases and further information about Hospira’s products and services, contribution to the community as well as product and corporate awards can be found by visiting www.hospira.com
Winners are chosen by our computer on a random basis. The prize is the client’s choice of $100 worth of selected laboratory items from our Perth warehouse.
